Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Nov 13, 2014

30071_dirs_2014-11-13_4fe01c60-cb08-455f-abf8-4f795fe02609.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-11-11

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-11 ResMed Common Stock M 2967 $33.70 Acquired 78417 Direct
2014-11-11 ResMed Common Stock F 2796 $51.15 Disposed 75621 Direct
2014-11-11 ResMed Common Stock F 2982 $51.15 Disposed 72639 Direct
2014-11-11 ResMed Common Stock F 1503 $51.15 Disposed 71136 Direct
2014-11-11 ResMed Common Stock F 1045 $51.15 Disposed 70091 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-11 ResMed Common Stock Options $33.70 M 2967 Disposed 2017-11-11 ResMed Common Stock (2967) Direct

Footnotes

F1: Represents date options first became available. Options vest 1/4 per year on the anniversary of the grant.

F2: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/11/2010 and vesting 11/11/2014.

F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/16/2011 and vesting 11/11/2014.

F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012 and vesting 11/11/2014.

F5: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013 and vesting 11/11/2014.